Welcome to Scribd, the world's digital library. Read, publish, and share books and documents. See more
Download
Standard view
Full view
of .
Look up keyword
Like this
1Activity
0 of .
Results for:
No results containing your search query
P. 1
Global Markets and Technologies for Optical Coherence Tomography (OCT)

Global Markets and Technologies for Optical Coherence Tomography (OCT)

Ratings: (0)|Views: 15|Likes:
Published by BCC Research
Optical coherence tomography (OCT) is a relatively new technology for performing high-resolution, cross-sectional imaging of tissue structure on the micron scale in situ and in real time.
Optical coherence tomography (OCT) is a relatively new technology for performing high-resolution, cross-sectional imaging of tissue structure on the micron scale in situ and in real time.

More info:

Categories:Types, Research
Published by: BCC Research on May 21, 2013
Copyright:Attribution Non-commercial

Availability:

Read on Scribd mobile: iPhone, iPad and Android.
download as DOC, PDF, TXT or read online from Scribd
See more
See less

10/10/2013

pdf

text

original

 
Global Markets and Technologies for Optical Coherence Tomography (OCT)
WELLESLEY, Mass. – Optical coherence tomography (OCT) is a relatively new technologyfor performing high-resolution, cross-sectional imaging of tissue structure on the micronscale in situ and in real time. OCT has emerged as a powerful optical imaging instrument andtechnology. OCT performs high-resolution, cross-sectional tomographic imaging of theinternal structure in 3-D materials, including biological tissues.The features of OCT that make it an important technology for biomedical imaging,ophthalmic imaging, nontransparent tissue imaging are where conventional excisional biopsyis hazardous or impossible, and/or cases in which conventional biopsy has an unacceptablyhigh false negative rate because of sampling errors and to provide guidance during surgicalinterventional procedures.The development of high-resolution and high-speed OCT technology as well as OCTcompatible catheter/endoscopes and other delivery systems represent the future of OCTimaging clinical applications. The unique capabilities of OCT imaging make it an idealchoice for the diagnosis and clinical management of many diseases. In 2010, the total revenueof the OCT market was $525.7 million; it increased to $645.4 million in 2012.Emerging OCT technologies are poised to expand the scope of OCT imaging. Research isexpected to enhance the clinical approach to the diagnosis and management of patients withretinal disease and cancer. The in-depth understanding of these technologies, their potentialadvantages and disadvantages will aid clinics and research institutes in optimally using thesenew methods. The current applications of OCT include dental and periodontal applications,dermatology, developmental biology, ear canal measurements for customization of hearingaids, flow measurement in engineered tissue, guided surgery, molecular imaging protein- based molecular contrast OCT, monitoring the concentration of photosensitizers in photodynamic therapy (PDT), oncology, pharmaceutical research, small animal imaging,tissue engineering, and in bioreactors.The polarization sensitive-OCT (PS-OCT) and time domain-OCT (TD-OCT) market is poised for continued growth, with revenues of $50.9 million in 2012. This is due to increasein number of applications and studies involving PS and TD optical coherence tomographytechnology.The market of the Fourier or spectral domain OCT has increased at a steady pace. The growthin the spectral domain OCT (SD-OCT) technology is due to extensive use of this technologyin oncology, cardiology, ophthalmology, and other biomedical fields. The main contributionfor this growth is a scanning rate feature of SD-OCT.Time-encoded OCT does not lack from inherent sensitivity degradation at longer imagingdepths, as compared to Fourier domain OCT technology; hence, time-encoded OCT systemsare the preferred choice where long imaging depths are desired.The biotechnology sector for TD-OCT and PS-OCT is growing at a compound annual growthrate (CAGR) of 10.4% and is predicted to reach $25.6 million by 2017. The U.S. Food andDrug Administration (FDA) approval of TD-OCT devices has increased their demand, asthese devices are now readily available for biotechnological research. The primary

You're Reading a Free Preview

Download
scribd
/*********** DO NOT ALTER ANYTHING BELOW THIS LINE ! ************/ var s_code=s.t();if(s_code)document.write(s_code)//-->